A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma.

Peng, Liang

A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II-IVa nasopharyngeal carcinoma. [electronic resource] - Oral oncology 11 2018 - 258-265 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1879-0593

10.1016/j.oraloncology.2018.10.007 doi


Adult
Cell-Free Nucleic Acids--blood
Chemoradiotherapy--methods
Clinical Decision-Making--methods
DNA, Viral--blood
Disease-Free Survival
Epstein-Barr Virus Infections--mortality
Female
Follow-Up Studies
Herpesvirus 4, Human--genetics
Humans
Induction Chemotherapy--methods
Kaplan-Meier Estimate
Male
Middle Aged
Models, Biological
Nasopharyngeal Carcinoma--mortality
Nasopharyngeal Neoplasms--mortality
Neoplasm Staging
Patient Selection
Prognosis
Proportional Hazards Models
Retrospective Studies